MedPath

External Fixator or Antibiotic-coated Plate in Severe Open Long Bone Fractures

Not Applicable
Not yet recruiting
Conditions
Fracture Related Infection
Registration Number
NCT06193330
Lead Sponsor
Oluwasegun Aremu
Brief Summary

The purpose of the study is to assess whether infection rate is reduced with use of antibiotic-coated plate in severe open tibial fractures compare to use of external fixators

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
178
Inclusion Criteria
  • Age ≥ 18yrs,
  • Gustilo-Anderson IIIA and IIIB open fractures,
  • involvement of any long bone fractures that can be fixed with either plate or uniplanar external fixation,
  • wound can be closed primarily, with skin graft or flap, or can heal secondarily
Exclusion Criteria
  • Patients with traumatic brain injury,

  • spinal cord injury,

  • severe burns,

    • 1 long bone fractures,
  • refusal to consent,

  • history of allergies to ceftriaxone or sulbactam,

  • fractures associated with vascular injury

  • and non-compliance with follow-up.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
number of participants with fracture-related infection after 1 yearone year

participants will be followed-up for one year and occurrence of infection at any point during this time period will be noted and recorded once

Secondary Outcome Measures
NameTimeMethod
number of participants who require re-operation after one yearone year

during the course of follow-up, Patients with infection or other complications like malunion or non-union who require surgical intervention to achieve union will be noted and recorded

number of participants who have fracture union after one yearone year

participants will be assessed clinically and radiologically at 3months, 6months, and one year

change in 12-item Short Form Survey (SF-12) score at baseline and at one year follow-upone year

SF-12 score of participants will be taking at baseline and also at one year of follow-up and these two scores will be assessed to determine any differences

Trial Locations

Locations (2)

Federal Medical Centre, Owo

🇳🇬

Owo, Ondo State, Nigeria

Univeristy College Hospital, Ibadan, Nigeria

🇳🇬

Ibadan, Oyo, Nigeria

Federal Medical Centre, Owo
🇳🇬Owo, Ondo State, Nigeria

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.